Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro
- PMID: 18094037
- DOI: 10.1124/dmd.107.018820
Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro
Abstract
Induction of drug enzyme activity in the intestine can strongly determine plasma levels of drugs. It is therefore important to predict drug-drug interactions in human intestine in vitro. We evaluated the applicability of human intestinal precision-cut slices for induction studies in vitro. Morphological examination and intracellular ATP levels indicated tissue integrity up to 24 h of incubation, whereas in proximal jejunum slices, the metabolic rate toward most substrates remained at 40 to 50% of initial values. In colon slices, the cytochrome P450 conversions were below the detection limit, but conjugation rates remained relatively constant during incubation. The inducibility of drug-metabolizing enzymes and P-glycoprotein was evaluated using prototypical inducers for five induction pathways. beta-Naphthoflavone (aryl hydrocarbon receptor ligand) induced CYP1A1 (132-fold in colon and 362-fold in proximal jejunum) and UDP glucuronosyltransferase (UGT) 1A6 mRNA (9.8-fold in colon and 3.2-fold in proximal jejunum). In proximal jejunum, rifampicin (RIF) [pregnane X receptor (PXR) ligand] induced CYP3A4 (5.2-fold), CYP2B6 (2-fold), UGT1A6 (2.2-fold), and multidrug resistance-1 (MDR1)/ABCB1 mRNA (2.7-fold), whereas 6beta-hydroxytestosterone formation (CYP3A4) increased 2-fold. In colon, RIF induced UGT1A6 32-fold and MDR1 2.2-fold. Dexamethasone (glucocorticoid receptor and PXR ligand) induced CYP3A4 mRNA (3.5-fold) and activity (5-fold) in proximal jejunum. Phenobarbital (constitutive androstane receptor activator) induced CYP3A4 (4.1-fold, only in jejunum), CYP2B6 (4.9-fold in colon and 2.3-fold in proximal jejunum), and MDR1/ABCB1 mRNA and CYP3A4 activity (2-fold only proximal jejunum). Quercetin (nuclear factor-E2-related factor 2 activator) induced UGT1A6 mRNA (6.7-fold in colon and 2.2-fold in proximal jejunum). In conclusion, this study shows that human intestinal precision-cut slices are useful to study induction of drug-metabolizing enzymes and transporters in the human intestine.
Similar articles
-
Induction of phase I and II drug metabolism in rat small intestine and colon in vitro.Drug Metab Dispos. 2007 Jun;35(6):898-907. doi: 10.1124/dmd.106.014563. Epub 2007 Mar 7. Drug Metab Dispos. 2007. PMID: 17344336
-
Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.Arch Toxicol. 2008 Dec;82(12):959-64. doi: 10.1007/s00204-008-0312-z. Epub 2008 May 17. Arch Toxicol. 2008. PMID: 18488193 Free PMC article.
-
Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations.Drug Metab Dispos. 2006 Nov;34(11):1893-902. doi: 10.1124/dmd.106.011148. Epub 2006 Aug 16. Drug Metab Dispos. 2006. PMID: 16914511
-
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.Curr Drug Metab. 2008 May;9(4):310-22. doi: 10.2174/138920008784220664. Curr Drug Metab. 2008. PMID: 18473749 Review.
-
Induction of phase I, II and III drug metabolism/transport by xenobiotics.Arch Pharm Res. 2005 Mar;28(3):249-68. doi: 10.1007/BF02977789. Arch Pharm Res. 2005. PMID: 15832810 Review.
Cited by
-
Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.Nat Protoc. 2010 Sep;5(9):1540-51. doi: 10.1038/nprot.2010.111. Epub 2010 Aug 19. Nat Protoc. 2010. PMID: 20725069
-
Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model.Elife. 2020 Jan 14;9:e50135. doi: 10.7554/eLife.50135. Elife. 2020. PMID: 31933478 Free PMC article.
-
Inhibitory effects of quercetin and its major metabolite quercetin-3-O-β-D-glucoside on human UDP-glucuronosyltransferase 1A isoforms by liquid chromatography-tandem mass spectrometry.Exp Ther Med. 2021 Aug;22(2):842. doi: 10.3892/etm.2021.10274. Epub 2021 Jun 6. Exp Ther Med. 2021. PMID: 34149888 Free PMC article.
-
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients: A Physiologically Based Pharmacokinetic Modeling Study.Clin Pharmacol Ther. 2025 Feb;117(2):554-560. doi: 10.1002/cpt.3491. Epub 2024 Nov 13. Clin Pharmacol Ther. 2025. PMID: 39535447 Free PMC article.
-
Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap.Front Pharmacol. 2022 Oct 7;13:962718. doi: 10.3389/fphar.2022.962718. eCollection 2022. Front Pharmacol. 2022. PMID: 36278150 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical